The Association Between the rs1805329 of Rad23B Polymorphism and Severity of Lung Complications of Patients Exposed to Sulfur Mustard in Long Term

Document Type : Original Article

Authors

1 Department of Biology, ّScience and Research Branch, Islamic Azad University, Tehran, Iran.

2 Immunoregulation Research Center, Shahed University, Tehran, Iran.

3 Department of Biostatistics and Social Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.

Abstract

Background: During the Iran-Iraq war, the Iraqi regime frequently used sulfur mustard gas as a weapon in various residential areas, including Sardasht, causing multiple and severe long-term destructive effects on all living organisms, including humans. The pulmonary system is among the most essential organs with varying severity involved in sulfur mustard chemotoxicity in the long term. This study aimed to evaluate the effects of Rad23B (rs1805329) polymorphism on the severity of lung complications in patients exposed to SM gas 30 years ago.
Materials and Methods: The study explored 106 severe and 105 mild PBMC patients exposed to SM gas. Furthermore, 47 PBMC samples were added to the study as a non-exposed group (control). Genotyping of rs1805329 was performed using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).
Results: The results revealed no significant differences in genotype frequencies between the mild, severe, and the unexposed group. Moreover, no statistically significant difference was observed in genotypic frequency in all co-dominant, dominant, recessive, and over-dominant models.
Conclusion: The obtained data indicated that the rs1805329 of Rad23B was not associated with the severity of the lung complications of patients exposed to sulfur mustard 30 years ago.

Keywords

References

  1. Collins-Wildman DL, Sullivan KP, Geletii YV, Snider VG, Gordon WO, Balboa A, et al. A solvent-free solid catalyst for the selective and color-indicating ambient-air removal of sulfur mustard. Communications Chemistry. 2021; 4(1):1-7. [DOI:10.1038/s42004-021-00465-7]
  2. Tang FR, Loke WK. Sulfur mustard and respiratory diseases. Critical Reviews in Toxicology. 2012; 42(8):688-702. [DOI:10.3109/10408444.2012.698405] [PMID]
  3. Razavi SM, Salamati P, Saghafinia M, Abdollahi M. A review on delayed toxic effects of sulfur mustard in Iranian veter Daru: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 2012; 20(1):51. [DOI:10.1186/2008-2231-20-51] [PMID] [PMCID]
  4. Shams J, Ghazanfari T, Yaraee R, Mahdavi MRV, Soroush MR, Hassan ZM, et al. Long-term hematological consequences of sulfur mustard on civilians of Sardasht 20 years after exposure. Toxin Reviews. 2009; 28(1):39-43. [DOI:10.1080/15569540802689626]
  5. Darchini-Maragheh E, Balali-Mood M. Delayed complications and long-term management of sulfur mustard poisoning: Recent advances by iranian researchers (Part I of II). Iranian Journal of Medical Sciences. 2018; 43(2):103-24. [PMID] [PMCID]
  6. Ghanei M, Harandi AA. Long term consequences from exposure to sulfur mustard: A review. Inhalation Toxicology. 2007; 19(5):451-6. [DOI:10.1080/08958370601174990] [PMID]
  7. Rowell M, Kehe K, Balszuweit F, Thiermann H. The chronic effects of sulfur mustard exposure. Toxicology. 2009; 263(1):9-11. [DOI:10.1016/j.tox.2009.05.015] [PMID]
  8. Ghasemi, H, Ghazanfari T, Ghassemi-Broumand M, Javadi MA, Babaei M, Soroush MR, et al. Long-term ocular consequences of sulfur mustard in seriously eye-injured war veterans. Cutaneous and Ocular Toxicology. 2009; 28(2):71-7. [DOI:10.1080/15569520902913936] [PMID]
  9. Shohrati M, Amini-Harandi A, Najafian B, Saburi A, Ghanei M. The role of serum level of interleukin-6 in severity of pulmonary complications of sulfur mustard injuries. Iranian Journal of Medical Sciences. 2014; 39(4):382-6. [PMID] [PMCID]
  10. Taravati A, Ardestani SK, Ziaee AA, Ghorbani A, Soroush MR, Faghihzadeh S, et al. Effects of paraoxonase 1 activity and gene polymorphisms on long-term pulmonary complications of sulfur mustard-exposed veterans. International Immunopharmacology. 2013; 17(3):974-9. [DOI:10.1016/j.intimp.212.026] [PMID]
  11. Hajizadeh Dastjerdi A, Behboudi H, Kianmehr Z, Taravati A, Naghizadeh MM, Kaboudanian Ardestani S, et al. Association of glutathione S-transferase polymorphisms with the severity of mustard lung. Bioimpacts. 2017; 7(4):255-61. [DOI:10.15171/bi.2017.30] [PMID] [PMCID]
  12. Fu D, Calvo JA, Samson LD. Balancing repair and tolerance of DNA damage caused by alkylating agents. Nature Reviews. Cancer. 2012; 12(2):104-20. [DOI:10.1038/nrc3185] [PMID] [PMCID]
  13. Khateri S, Balali-Mood M, Blain P, Williams F, Jowsey P, Soroush MR, et al. DNA damage and repair proteins in cellular response to sulfur mustard in Iranian veterans more than two decades after exposure. Toxicology Letters. 2018; 293:67-72. [DOI:10.1016/j.2017.12.001] [PMID]
  14. Friedberg EC. How nucleotide excision repair protects against cancer. Nature Reviews. Cancer. 2001; 1(1):22-33. [DOI:10.1038/35094000] [PMID]
  15. Marteijn JA, Lans H, Vermeulen W, Hoeijmakers JHJ. Understanding nucleotide excision repair and its roles in cancer and ageing. Nature Reviews. Molecular Cell Biology. 2014; 15(7):465-81. [DOI:10.1038/nrm3822] [PMID]
  16. Khateri S, Ghanei M, Keshavarz S, Soroush M, Haines D. Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians with wartime exposure to mustard agent. Journal of Occupational and Environmental Medicine. 2003; 45(11):1136-43. [DOI:10.1097/01.jom.0000094993.20914.d1] [PMID]
  17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research. 1988; 16(3):1215. [DOI:10.1093/nar/16.3.1215] [PMID] [PMCID]
  18. Tahmasbpour E, Emami SR, Ghanei M, Panahi Y. Role of oxidative stress in sulfur mustard-induced pulmonary injury and antioxidant protection. Inhalation Toxicology. 2015; 27(13):659-72. [DOI:10.3109/08958378.2015.1092184] [PMID]
  19. Ghanei M, Harandi AA. Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: A review. Inhalation Toxicology. 2011; 23(7):363-71. [DOI:10.3109/08958378.2011.576278] [PMID]
  20. Li Z, Zhang Y, Ying X, Song J, Zhang R, Li Z, et al., The association between RAD23B Ala249Val polymorphism and cancer susceptibility: Evidence from a meta-analysis. PLoS One. 2014; 9(3):e91922. [DOI:10.1371/journal.pone.0091922] [PMID] [PMCID]
  21. Shen, M, Berndt SI, Rothman N, Demarini DM, Mumford JL, He X, et al. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. International Journal of Cancer. 2005; 116(5):768-73. [DOI:10.1002/i21117] [PMID]
  22. Tomoda T, Nouso K, Sakai A, Ouchida M, Kobayashi S, Miyahara K, et al. Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: A case control study. Journal of Gastroenterology and Hepatology. 2012; 27(4):797-804. [DOI:10.1111/j.1440-1746.2011.06948.x] [PMID]
  23. Santos LS, Gomes BC, Gouveia R, Silva SN, Azevedo AP, Camacho V, et al. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer. Oncology Reports. 2013; 30(5):2458-66. [DOI:10.3892/or.2013.2702] [PMID]
Immunoregulation
Volume 4, Issue 2
January 2021
Pages 109-116

Files

Share

How to cite

Statistics